Literature DB >> 708106

Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis.

J Schaub, S Däumling, H C Curtius, A Niederwieser, K Bartholomé, M Viscontini, B Schircks, J H Bieri.   

Abstract

A patient with atypical phenylketonuria (defective BH2 synthesis), detected at age 6 months because of severe muscle hypotonia and serum phenylalanine of 20 mg/100 ml, had normal activities of phenylalanine-4-hydroxylase and DHPR in liver biopsy, but only 2% activity in the phenylalanine-4-hyroxylase in vivo test using deuterated phenylalanine. After IV administration of 2.5 mg/kg chemically pure tetrahydrobiopterin bishydrochloride (BH4 . 2HCl), serum phenylalanine decreased from 20.4 to 2.1 mg/100 ml within 3 hours. Administration of 25 mg BH4 . HCl and 100 mg ascorbic acid through a gastric tube decrease; serum phenylalanine from 13.7 to less than 1.6 mg/100 ml within 3 hours and it remained less than 2 mg/100 ml for 2 days.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 708106      PMCID: PMC1545051          DOI: 10.1136/adc.53.8.674

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  Phenylketonuria due to a deficiency of dihydropteridine reductase.

Authors:  S Kaufman; N A Holtzman; S Milstien; L J Butler; A Krumholz
Journal:  N Engl J Med       Date:  1975-10-16       Impact factor: 91.245

2.  In vivo enhancement of tyrosine hydroxylation in rat striatum by tetrahydrobiopterin.

Authors:  R Kettler; G Bartholini; A Pletscher
Journal:  Nature       Date:  1974-05-31       Impact factor: 49.962

3.  Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.

Authors:  K Bartholomé; D J Byrd; S Kaufman; S Milstien
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

4.  Letter: Tetrahydrobiopterin treatment of variant form of phenylketonuria.

Authors:  D M Danks; R G Cotton; P Schlesinger
Journal:  Lancet       Date:  1975-11-22       Impact factor: 79.321

5.  Determination of phenylalanine hydroxylase activity in patients with phenylketonuria and hyperphenylalaninemia.

Authors:  K Bartholomé; P Lutz; H Bickel
Journal:  Pediatr Res       Date:  1975-12       Impact factor: 3.756

6.  The use of deuterated phenylalanine for the elucidation of the phenylalanine-tyrosine metabolism.

Authors:  H C Curtius; J A Völlmin; K Baerlocher
Journal:  Clin Chim Acta       Date:  1972-03       Impact factor: 3.786

7.  In vivo studies of the phenylalanine-4-hydroxylase system in hyperphenylalaninemics and phenylketonurics.

Authors:  H C Curtius; M J Zagalak; K Baerlocher; J Schaub; W Leimbacher; U Redweik
Journal:  Helv Paediatr Acta       Date:  1978-02
  7 in total
  13 in total

1.  Atypical phenylketonuria with "dihydrobiopterin synthetase" deficiency: absence of phosphate-eliminating enzyme activity demonstrated in liver.

Authors:  A Niederwieser; W Leimbacher; H C Curtius; A Ponzone; F Rey; D Leupold
Journal:  Eur J Pediatr       Date:  1985-05       Impact factor: 3.183

2.  Hyperphenylalaninemia due to impaired dihydrobiopterin biosynthesis.

Authors:  T Tanaka; K Aihara; K Iwai; M Kohashi; K Tomita; K Narisawa; N Arai; H Yoshida; T Usui
Journal:  Eur J Pediatr       Date:  1981-07       Impact factor: 3.183

3.  Diagnosis of malignant hyperphenylalaninaemia.

Authors:  D M Danks; R G Cotton; P Schlesinger
Journal:  Arch Dis Child       Date:  1979-05       Impact factor: 3.791

Review 4.  Phenylketonuria: Current Treatments and Future Developments.

Authors:  Uta Lichter-Konecki; Jerry Vockley
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

Review 5.  Disorders of biopterin metabolism.

Authors:  Nicola Longo
Journal:  J Inherit Metab Dis       Date:  2009-02-09       Impact factor: 4.982

6.  Biopterin synthesis defect. Treatment with L-dopa and 5-hydroxytryptophan compared with therapy with a tetrahydropterin.

Authors:  R R McInnes; S Kaufman; J J Warsh; G R Van Loon; S Milstien; G Kapatos; S Soldin; P Walsh; D MacGregor; W B Hanley
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

7.  Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening and study of biosynthesis in man.

Authors:  A Niederwieser; H C Curtius; M Wang; D Leupold
Journal:  Eur J Pediatr       Date:  1982-03       Impact factor: 3.183

8.  Dihydrobiopterin biosynthesis deficiency.

Authors:  J L Dhondt; B Leroux; J P Farriaux; C Largilliere; R J Leeming
Journal:  Eur J Pediatr       Date:  1983-12       Impact factor: 3.183

9.  Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study.

Authors:  Jun Ye; Yanling Yang; Weimin Yu; Hui Zou; Jianhui Jiang; Rulai Yang; Sunny Shang; Xuefan Gu
Journal:  J Inherit Metab Dis       Date:  2012-11-09       Impact factor: 4.982

Review 10.  Phenylketonuria: a review of current and future treatments.

Authors:  Naz Al Hafid; John Christodoulou
Journal:  Transl Pediatr       Date:  2015-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.